| 03-15-2011 12:52 PM CET - Politics, Law & Society |
|
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of AHII
Press release from: Levi & Korsinsky, LLP
Levi & Korsinsky is investigating the Board of Directors of Animal Health International, Inc. (“AHII” or the “Company”) (Nasdaq: AHII) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Lextron, Inc.
New York, NY, March 15, 2011 -- Levi & Korsinsky is investigating the Board of Directors of Animal Health International, Inc. (“AHII” or the “Company”) (Nasdaq: AHII) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Lextron, Inc. Under the terms of the transaction, AHII shareholders will receive $4.25 per share for each AHII share they own. The transaction has a value of approximately $111 million, plus the repayment of AHII’s outstanding indebtnedness, for a total purchase price of approximately $251 million.
Click here to learn how to join the action: www.zlk.com/animal-health-ahii.html, or call: 877-363-5972.
The investigation concerns whether the AHII Board of Directors breached their fiduciary duties to AHII stockholders by failing to adequately shop the Company before entering into this transaction and whether Lextron is underpaying for AHII shares, thus unlawfully harming AHII stockholders. In particular, at least one analyst set a price target of $5.00 per share of AHII stock.
If you own common stock in AHII and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit www.zlk.com/animal-health-ahii.html.
Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Levi & Korsinsky, LLP, Joseph Levi, Esq., Eduard Korsinsky, Esq., 30 Broad Street - 15th Floor, New York, NY 10004, Tel: (212) 363-7500, Toll Free: (877) 363-5972, Fax: (212) 363-7171, www.zlk.com
Contact:
Joanna Chlebus
Levi & Korsinsky, LLP
30 Broad St.
15th Floor
New York, NY 10004
212-363-7500
jchlebus@zlk.com
www.zlk.com
Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation.
Joanna Chlebus
Levi & Korsinsky, LLP
30 Broad St.
15th Floor
New York, NY 10004
212-363-7500
jchlebus@zlk.com
www.zlk.com
This release was published on openPR.
New York, NY, March 15, 2011 -- Levi & Korsinsky is investigating the Board of Directors of Animal Health International, Inc. (“AHII” or the “Company”) (Nasdaq: AHII) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Lextron, Inc. Under the terms of the transaction, AHII shareholders will receive $4.25 per share for each AHII share they own. The transaction has a value of approximately $111 million, plus the repayment of AHII’s outstanding indebtnedness, for a total purchase price of approximately $251 million.
Click here to learn how to join the action: www.zlk.com/animal-health-ahii.html, or call: 877-363-5972.
The investigation concerns whether the AHII Board of Directors breached their fiduciary duties to AHII stockholders by failing to adequately shop the Company before entering into this transaction and whether Lextron is underpaying for AHII shares, thus unlawfully harming AHII stockholders. In particular, at least one analyst set a price target of $5.00 per share of AHII stock.
If you own common stock in AHII and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit www.zlk.com/animal-health-ahii.html.
Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Levi & Korsinsky, LLP, Joseph Levi, Esq., Eduard Korsinsky, Esq., 30 Broad Street - 15th Floor, New York, NY 10004, Tel: (212) 363-7500, Toll Free: (877) 363-5972, Fax: (212) 363-7171, www.zlk.com
Contact:
Joanna Chlebus
Levi & Korsinsky, LLP
30 Broad St.
15th Floor
New York, NY 10004
212-363-7500
jchlebus@zlk.com
www.zlk.com
Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation.
Joanna Chlebus
Levi & Korsinsky, LLP
30 Broad St.
15th Floor
New York, NY 10004
212-363-7500
jchlebus@zlk.com
www.zlk.com
This release was published on openPR.
News-ID: 166535
|
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
© openPR 2012 | Imprint
More Releases from
Levi & Korsinsky, LLP
Comments about openPR
OpenPR ist the nicest and most clearly laid out PR platform I have seen to this day. The press releases are displayed very nicely and clearly and without any unnecessary frills.
The updates are fast and the finished release looks appealing and is clearly legible.
Even with 16 years of experience one discovers new things from time to time.
Congratulations!
Gabriele Ketterl,Director Marketing & PR, Menads
The updates are fast and the finished release looks appealing and is clearly legible.
Even with 16 years of experience one discovers new things from time to time.
Congratulations!
Gabriele Ketterl,Director Marketing & PR, Menads